... a novel delivery platform for regenerative cells & biotherapeutics to treat or cure devastating and costly chronic diseases.
Stage
Product In Development
Industry
Biotechnology
Location
St Paul, MN, US
Currency
USD
Founded
October 2010
Employees
4
Incorporation Type
LLC
Company Summary
NanoVault (NV) develops implantable metallic capsules, using nanotechnology-derived materials to safely deliver regenerative cells & biotherapeutics.
Initial target is insulin-producing Beta cells. NV's immune-isolation capsule could be used by 13M U.S. diabetics.
Our License/Royalty & Manufacturing model targets 300+ firms and major divisions working in Regenerative Medicine. Five-year revenues of $3B.
The Company seeks a $350,000.